These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 16159435)

  • 1. [Detection of sentinel lymph node in patients with early stage breast cancer].
    Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
    Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node pressure in breast cancer.
    Nathanson SD; Mahan M
    Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
    Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
    Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
    Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
    Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
    Ge J; Yan B; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in male breast cancer patients.
    Goyal A; Horgan K; Kissin M; Yiangou C; Sibbering M; Lansdown M; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M;
    Eur J Surg Oncol; 2004 Jun; 30(5):480-3. PubMed ID: 15135473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node biopsy in ductal carcinoma in situ patients.
    Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
    Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.
    McMasters KM; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Dirk Noyes R; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Edwards MJ
    Ann Surg; 2000 May; 231(5):724-31. PubMed ID: 10767794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
    Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
    Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.